Abstract
The main goal of this study is to compare the effects on public health of the second wave of the COVID-19 pandemic compared to first wave in society. The paper here focuses on a case study of Italy, one of the first European countries to experience a rapid increase in confirmed cases and deaths. Methodology considers daily data from February to November 2020 of the ratio of confirmed cases/total swabs, fatality rate (deaths / confirmed cases) and ratio of individuals in Intensive Care Units (ICUs) / Confirmed cases. Results reveal that the first wave of COVID-19 pandemic in Italy had a strong but declining impact on public health with the approaching of summer season and with the effects of containment measures, whereas second wave of the COVID-19 has a growing trend of confirmed cases with admission to ICUs and total deaths having a, to date, lower impact on public health compared to first wave. Although effects of the first wave of the COVID-19 pandemic on public health, policymakers have had an unrealistic optimist behavior that a new wave of COVID-19 could not hit their countries and, especially, a low organizational capacity to plan effective policy responses to cope with recurring COVID-19 pandemic crisis. This study can support vital information to design effective policy responses of crisis management to constrain current and future waves of the COVID-19 pandemic and similar epidemics in society.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable', research does not report on or involve the use of any animal or human data or tissue
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
data are on: Ministero della Salute 2020. Covid-19 - Situazione in Italia. http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area=nuovoCoronavirus&menu=vuoto
